GR75097B - - Google Patents

Info

Publication number
GR75097B
GR75097B GR66267A GR810166267A GR75097B GR 75097 B GR75097 B GR 75097B GR 66267 A GR66267 A GR 66267A GR 810166267 A GR810166267 A GR 810166267A GR 75097 B GR75097 B GR 75097B
Authority
GR
Greece
Application number
GR66267A
Inventor
Billie Kenneth Koe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR75097B publication Critical patent/GR75097B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR66267A 1980-10-17 1981-10-13 GR75097B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/197,872 US4320124A (en) 1980-10-17 1980-10-17 Composition for enhancing binding of a benzodiazepine to central benzodiazepine receptors and use thereof

Publications (1)

Publication Number Publication Date
GR75097B true GR75097B (el) 1984-07-13

Family

ID=22731077

Family Applications (1)

Application Number Title Priority Date Filing Date
GR66267A GR75097B (el) 1980-10-17 1981-10-13

Country Status (10)

Country Link
US (1) US4320124A (el)
EP (1) EP0050487B1 (el)
JP (1) JPS5795912A (el)
KR (1) KR830007074A (el)
AU (1) AU529307B2 (el)
DE (1) DE3166349D1 (el)
GR (1) GR75097B (el)
IL (1) IL64062A0 (el)
NZ (1) NZ198657A (el)
PT (1) PT73746B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
US6031098A (en) * 1997-08-11 2000-02-29 California Institute Of Technology Detection and treatment of duplex polynucleotide damage
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US20090156565A1 (en) * 2004-12-03 2009-06-18 The Children's Hospital Of Philadelphia Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
HU180917B (hu) * 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents

Also Published As

Publication number Publication date
IL64062A0 (en) 1982-01-31
JPS5795912A (en) 1982-06-15
AU529307B2 (en) 1983-06-02
PT73746A (en) 1981-10-01
US4320124A (en) 1982-03-16
NZ198657A (en) 1985-05-31
DE3166349D1 (en) 1984-10-31
AU7651781A (en) 1982-04-22
EP0050487A1 (en) 1982-04-28
PT73746B (en) 1983-11-08
EP0050487B1 (en) 1984-09-26
KR830007074A (ko) 1983-10-14

Similar Documents

Publication Publication Date Title
FR2475270B1 (el)
FR2473466B1 (el)
IN154964B (el)
FR2473227B1 (el)
FR2473725B1 (el)
FR2475102B1 (el)
FR2475115B1 (el)
FR2473981B1 (el)
FR2474036B1 (el)
FR2474476B1 (el)
FR2474047B1 (el)
FR2474808B1 (el)
FR2474065B1 (el)
FR2473926B1 (el)
FR2473558B1 (el)
FR2474710B2 (el)
FR2473214B1 (el)
FR2474867B1 (el)
FR2474627B1 (el)
FR2473586B1 (el)
FR2486427B1 (el)
GR75097B (el)
FR2474174B1 (el)
FR2475129B1 (el)
FR2475228B1 (el)